Home›Companies›Biotech & Pharma›Skylark Bio

Skylark Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 19, 2024·Suggest an edit

About Skylark Bio

Skylark Bio is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $40,889,315 raised in one offering on Form D since August 2022. Its chief executive is Jodi Cook.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 8, 2022Aug 16, 2022amended Apr 19, 2024$40,889,315fully sold2$20.4MEquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Skylark Bio's Form D filed Apr 19, 2024.

SG
Steve Gillis
Director
JC
Jodi Cook
President and Chief Executive Officer, director
WM
Will McLean
Executive officer

Sources

  1. SECSkylark Bio, Inc. Form D/A, filed Aug 14, 2023
  2. SECSkylark Bio, Inc. Form D, filed Aug 16, 2022
  3. SECSkylark Bio, Inc. filing history